BRAF and colorectal carcinoma: We surveyed patients in the GSE39582 cohort for the seven most frequent mutations in codons 12 or 13 of KRAS15 and for the c.1799T > A (p.V600E) mutation of BRAF, and we found that mPS_colon was also able to stratify the prognosis of CRC patients with these mutations (Fig. 2c, d).